Ubs Group Ag Precision Biosciences Inc Transaction History

Ubs Group Ag

  • $452 Billion
  • Q3 2024

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024
BUY
$0.29 - $0.45 $2,606 - $4,044
8,988 Added 11.27%
88,736 $31,000
Q3 2023

Nov 09, 2023
BUY
$0.34 - $0.69 $5,073 - $10,295
14,921 Added 23.02%
79,748 $27,000
Q2 2023

Aug 11, 2023
BUY
$0.52 - $0.91 $32,072 - $56,126
61,678 Added 1958.65%
64,827 $34,000
Q1 2023

May 12, 2023
SELL
$0.7 - $1.41 $10,613 - $21,378
-15,162 Reduced 82.8%
3,149 $2,000
Q4 2022

Feb 08, 2023
BUY
$0.97 - $45.0 $14,167 - $657,270
14,606 Added 394.22%
18,311 $21,000
Q3 2022

Nov 10, 2022
BUY
$1.22 - $40.8 $3,118 - $104,284
2,556 Added 222.45%
3,705 $5,000
Q1 2022

May 16, 2022
SELL
$2.96 - $7.76 $422,865 - $1.11 Million
-142,860 Reduced 99.2%
1,149 $4,000
Q4 2021

Feb 14, 2022
BUY
$7.4 - $11.66 $426,247 - $671,627
57,601 Added 66.66%
144,009 $1.07 Million
Q3 2021

Nov 15, 2021
BUY
$9.18 - $14.15 $634,484 - $977,991
69,116 Added 399.7%
86,408 $997,000
Q2 2021

Aug 13, 2021
SELL
$8.07 - $12.52 $2.52 Million - $3.92 Million
-312,879 Reduced 94.76%
17,292 $217,000
Q1 2021

May 12, 2021
BUY
$8.57 - $15.79 $1.66 Million - $3.06 Million
193,493 Added 141.57%
330,171 $3.42 Million
Q4 2020

Feb 11, 2021
SELL
$5.98 - $12.47 $391,080 - $815,513
-65,398 Reduced 32.36%
136,678 $1.14 Million
Q3 2020

Nov 12, 2020
BUY
$4.65 - $8.73 $876,427 - $1.65 Million
188,479 Added 1386.18%
202,076 $1.25 Million
Q2 2020

Jul 31, 2020
SELL
$4.66 - $8.7 $13,579 - $25,351
-2,914 Reduced 17.65%
13,597 $114,000
Q1 2020

May 01, 2020
SELL
$5.05 - $15.01 $124,659 - $370,521
-24,685 Reduced 59.92%
16,511 $100,000
Q4 2019

Feb 14, 2020
BUY
$6.32 - $19.66 $234,408 - $729,189
37,090 Added 903.31%
41,196 $572,000
Q3 2019

Nov 14, 2019
SELL
$8.03 - $14.82 $471,200 - $869,637
-58,680 Reduced 93.46%
4,106 $34,000
Q2 2019

Aug 14, 2019
BUY
$11.88 - $16.94 $635,449 - $906,103
53,489 Added 575.34%
62,786 $832,000
Q1 2019

May 14, 2019
BUY
$17.44 - $17.95 $162,139 - $166,881
9,297 New
9,297 $167,000

Others Institutions Holding DTIL

# of Institutions
7
Shares Held
2.56M
Call Options Held
0
Put Options Held
0
View Full List

About PRECISION BIOSCIENCES INC

DTIL Quotes by TradingView
  • Ticker DTIL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 110,818,000
  • Market Cap $584M
  • Description
  • Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...
More about DTIL
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email